Jeffrey Graves

Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

Thomas P. Lodise, Ben M. Lomaestro, Jeffrey Graves et al. · Antimicrobial Agents and Chemotherapy · 2008 · 577 citations · Full text

Renal Pathology, Pharmacotherapy, Antimicrobial Chemotherapy +23

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia Treated with Vancomycin

Thomas P. Lodise, Jeffrey Graves, A. Evans et al. · Antimicrobial Agents and Chemotherapy · 2008 · 551 citations · Full text

Mrsa Culture, Mrsa Bacteremia, Antibiotic Resistance +16

Predictors of 30-Day Mortality among Patients with <i>Pseudomonas aeruginosa</i> Bloodstream Infections: Impact of Delayed Appropriate Antibiotic Selection

Thomas P. Lodise, Nimish Patel, Andrea Lay‐Hoon Kwa et al. · Antimicrobial Agents and Chemotherapy · 2007 · 313 citations · Full text

Delayed Appropriate Therapy, Bacterial Pathogens, Logistic Analysis +18

Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemia

Thomas P. Lodise, Chris D. Miller, Jeffrey Graves et al. · Journal of Antimicrobial Chemotherapy · 2008 · 70 citations · Full text

Clinical Prediction Tool To Identify Patients with <i>Pseudomonas aeruginosa</i> Respiratory Tract Infections at Greatest Risk for Multidrug Resistance

Thomas P. Lodise, Christopher Miller, Jeffrey Graves et al. · Antimicrobial Agents and Chemotherapy · 2006 · 57 citations · Full text

Multidrug Resistance, Clinical Prediction Tool, Antibiotic Resistance +18